Center for Scientific Review; Notice of Closed Meetings, 35701-35702 [E8-14043]
Download as PDF
Federal Register / Vol. 73, No. 122 / Tuesday, June 24, 2008 / Notices
ebenthall on PRODPC60 with NOTICES
levels of delta-opioid receptors, such as
lung, breast and/or colon cancers. Since
there is an increasing demand of
radioligands for in vivo imaging of
peripheral opioid receptors, this
technology has the potential of
enhancing current practices of PET
imaging in oncology.
Available for licensing are
compositions and methods of locating
delta- and/or mu-opioid receptors
located in peripheral cancers, such as in
lung, breast, and/or colorectal cancer,
using opiate radioligands.
Applications: Non-invasive tool for
screening lung, breast, and/or colorectal
cancers. Diagnostic tool for use in PET
imaging.
Market: For 2007, it was projected
that close to 1.5 million Americans
would develop cancer.
PET imaging is steadily becoming a
technique of choice in oncology so
many of these patients will likely
undergo scans several times during their
treatment to assess the stage of their
disease. This is supported by rising
sales of FDG, which are expected to
reach $933 million by 2012.
Development Status: Early stage.
Inventors: Lawrence H. Lazarus
(NIEHS) et al.
Relevant Publication: KA Roth and JD
Barchas. Small cell carcinoma cell lines
contain opioid peptides and receptors.
Cancer 1986 Feb 15;57(4):769–773.
Patent Status: U.S. Provisional
Application No. 60/970,143 filed 05 Sep
2007 (HHS Reference No. E–317–2007/
0–US–01).
Licensing Status: Available for
licensing.
Licensing Contact: Charlene A.
Sydnor, PhD.; 301–435–4689;
sydnorc@mail.nih.gov.
Collaborative Research Opportunity:
The NIEHS Laboratory of Pharmacology,
Medicinal Chemistry Group, is seeking
statements of capability or interest from
parties interested in collaborative
research to further develop, evaluate, or
commercialize this technology. Please
contact Elizabeth Denholm, PhD.,
Director, NIEHS Office of Technology
Transfer, at 919–541–0981 or
denholme@mail.nih.gov for more
information.
Novel Isoform of KCNH2 for the
Treatment of Schizophrenia
Description of Technology:
Researchers at the NIH report the
discovery and characterization of a
novel isoform of the voltage-gated
potassium channel KCNH2. This novel
isoform is shown to control neurological
firing and has implication as a genetic
risk factor for schizophrenia. It is highly
expressed in the hippocampus of
VerDate Aug<31>2005
12:39 Jun 23, 2008
Jkt 214001
schizophrenic patients and also in
normal individuals who carry riskassociated alleles of KCNH2. This novel
isoform may be a suitable target for drug
development as is it minimally
expressed in the heart with the potential
to exert less adverse cardiovascular
side-effects, which is often a
consequence of currently available
antipsychotic drugs.
Available for licensing and
commercial development are nucleic
acids, polypeptides and antibodies
specific for this novel isoform, as well
as methods of screening for therapeutic
agents and predicting susceptibility to
schizophrenia.
Applications: Potential new
psychotherapeutic agent with less
cardiac side-effects. Potential drug
screening assay for identifying new
psychotherapeutic drugs. Potential
diagnostic tool for determining
susceptibility of schizophrenia.
Market: Schizophrenia is among the
most severe of the mental illnesses and
has a lifetime prevalence of
approximately 1% worldwide.
More than 2,000,000 Americans have
schizophrenia and it accounts for 2.5%
of U.S. health care costs and 75% of
expenditures for long-term mental
health.
Development Status: Early stage.
Inventors: Daniel R. Weinberger et al.
(NIMH).
Patent Status: U.S. Provisional
Application No. 60/920,220 filed 26 Mar
2007 (HHS Reference No. E–245–2006/
0–US–01).
PCT Application No. PCT/US2008/
057913 filed 21 Mar 2008 (HHS
Reference No. E–245–2006/0–PCT–02).
Licensing Status: Available for
licensing.
Licensing Contact: Charlene A.
Sydnor, PhD.; 301–435–4689;
sydnorc@mail.nih.gov.
Collaborative Research Opportunity:
The NIMH Clinical Brain Disorders
Branch is seeking statements of
capability or interest from parties
interested in collaborative research to
further develop, evaluate, or
commercialize potassium channel
isoform associated with schizophrenia.
Please contact Suzanne Winfield at 301–
402–4324/winfiels@mail.nih.gov for
more information.
Dated: June 13, 2008.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. E8–14257 Filed 6–23–08; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
35701
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Clinical
Research Grants in Diabetes, Endocrine and
Metabolic Diseases.
Date: July 1–2, 2008.
Time: 8 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Stuart B. Moss, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6170,
MSC 7892, Bethesda, MD 20892, 301–435–
1044, mossstua@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neurogenetics.
Date: July 8, 2008
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Joseph G. Rudolph, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186,
MSC 7844, Bethesda, MD 20892, 301–435–
2212, josephru@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Orthopaedics and Skeletal Biology.
Date: July 11, 2008.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\24JNN1.SGM
24JNN1
ebenthall on PRODPC60 with NOTICES
35702
Federal Register / Vol. 73, No. 122 / Tuesday, June 24, 2008 / Notices
Place: Doubletree Hotel, 1515 Rhode Island
Avenue, NW., Washington, DC 20005.
Contact Person: John P. Holden, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211,
MSC 7814, Bethesda, MD 20892, 301–496–
8551, holdenjo@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Neuropharmacology.
Date: July 14–15, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Christine L. Melchior,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5176,
MSC 7844, Bethesda, MD 20892, (301) 435–
1713, melchioc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neurodevices and Bioengineering.
Date: July 16, 2008.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Joseph G. Rudolph, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186,
MSC 7844, Bethesda, MD 20892, 301–435–
2212, josephru@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AIDS
Fellowship Review.
Date: July 29–August 1, 2008.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Hilary D. Sigmon, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
MSC 7852, Bethesda, MD 20892, (301) 594–
6377, sigmonh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts in Developmental Disabilities and
Childhood-Origin Psychopathology.
Date: August 5–6, 2008.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Maribeth Champoux, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3146,
VerDate Aug<31>2005
12:39 Jun 23, 2008
Jkt 214001
MSC 7759, Bethesda, MD 20892, 301–594–
3163, champoum@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 16, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–14043 Filed 6–23–08; 8:45 am]
Place: National Institute on Aging,
Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: William Cruce, PhD,
Health Scientist Administrator, Scientific
Review Office, National Institute on Aging,
National Institutes of Health, Room 2c212,
7201 Wisconsin Avenue, Bethesda, MD
20814, 301–402–7704, crucew@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: June 16, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–14044 Filed 6–23–08; 8:45 am]
BILLING CODE 4140–01–M
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Degenerative
and Dementing Disease of Aging.
Date: July 9, 2008.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Room 2C212, Bethesda, MD 20814,
(Telephone Conference Call).
Contact Person: Bita Nakhai, PhD,
Scientific Review Administrator, Scientific
Review Office, National Institute on Aging,
Gateway Bldg., 2c212, 7201 Wisconsin
Avenue, Bethesda, MD 20814, 301–402–
7701, nakhaib@nia.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Biochemical
Risk Markers.
Date: July 25, 2008.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Interagency Autism Coordinating
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
inform the Contact Person listed below
in advance of the meeting.
Name of Committee: Interagency Autism
Coordinating Committee (IACC).
Date: July 15, 2008.
Time: 9 a.m. to 4 p.m.
Agenda: Review strategic planning
workgroup comments on draft plan; discuss
and approve draft strategic plan for autism
spectrum disorder (ASD) research, summary
of advances in ASD research, and process for
implementation of strategic plan, report from
Services Subcommittee; scientific
presentation.
Place: Natcher Conference Center, National
Institutes of Health, Rooms E1 and E2, 45
Center Drive, Bethesda, MD.
Contact Person: Tanya Pryor, Interagency
Autism Coordinating Committee, National
Institute of Mental Health, NIH, 6001
Executive Boulevard, Room 6187, MSC 9669,
Bethesda, MD 20892–9669, (301) 443–7153,
pryort@mail.nih.gov.
Any member of the public interested in
presenting oral comments to the Committee
should notify the Contact Person listed on
this notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations should
submit a letter of intent, a brief description
of the organization represented, and a written
copy of their oral presentation in advance of
the meeting. Only one representative of an
E:\FR\FM\24JNN1.SGM
24JNN1
Agencies
[Federal Register Volume 73, Number 122 (Tuesday, June 24, 2008)]
[Notices]
[Pages 35701-35702]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-14043]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Clinical Research Grants in Diabetes, Endocrine and Metabolic
Diseases.
Date: July 1-2, 2008.
Time: 8 a.m. to 8 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Stuart B. Moss, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6170, MSC 7892, Bethesda, MD 20892, 301-435-
1044, mossstua@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Neurogenetics.
Date: July 8, 2008
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Joseph G. Rudolph, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186, MSC 7844, Bethesda, MD
20892, 301-435-2212, josephru@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Orthopaedics and Skeletal Biology.
Date: July 11, 2008.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
[[Page 35702]]
Place: Doubletree Hotel, 1515 Rhode Island Avenue, NW.,
Washington, DC 20005.
Contact Person: John P. Holden, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4211, MSC 7814, Bethesda, MD 20892, 301-496-
8551, holdenjo@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts: Neuropharmacology.
Date: July 14-15, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Christine L. Melchior, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5176, MSC 7844, Bethesda, MD
20892, (301) 435-1713, melchioc@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Neurodevices and Bioengineering.
Date: July 16, 2008.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Joseph G. Rudolph, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186, MSC 7844, Bethesda, MD
20892, 301-435-2212, josephru@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; AIDS Fellowship Review.
Date: July 29-August 1, 2008.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Hilary D. Sigmon, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216, MSC 7852, Bethesda, MD
20892, (301) 594-6377, sigmonh@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts in Developmental Disabilities and Childhood-
Origin Psychopathology.
Date: August 5-6, 2008.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maribeth Champoux, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3146, MSC 7759, Bethesda, MD
20892, 301-594-3163, champoum@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: June 16, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-14043 Filed 6-23-08; 8:45 am]
BILLING CODE 4140-01-M